InvenireX, a Newcastle-based BioTech company that aims to disrupt the market for PCR laboratory tests, has raised £500,000 in funding from DSW Ventures and XTX Ventures. InvenireX’s platform, which incorporates AI and programmable DNA or ‘nanites’, enables scientists to rapidly test raw material for biomarkers at minute concentrations without the need for pre-processing.  It could … Continue reading Newcastle BioTech aims to disrupt PCR test market